Responses
Regular and Young Investigator Award Abstracts
Cellular Therapies
334 CAR T engagers encoding immune checkpoint inhibitors and immune-relevant cytokines stimulate CAR T cell activity against hematologic and solid tumors
Compose a Response to This Article
Other responses
No responses have been published for this article.